Clean intermittent catheterisation: Which are our patients' preferred catheters?

OSORIO OSPINA F1, QUINTANA FRANCO L1, MONREAL GUIJARRO J1, GARCIANDIA ESQUISABEL A1, TRIGOS ROMERO S1, GONZÁLEZ LÓPEZ R1, GARDE GARCÍA H1, GONZÁLEZ ENGUITA C1

Research Type

Clinical

Abstract Category

Continence Care Products / Devices / Technologies

Abstract 642
Open Discussion ePosters
Scientific Open Discussion Session 105
Thursday 24th October 2024
14:10 - 14:15 (ePoster Station 5)
Exhibition Hall
Voiding Dysfunction Detrusor Hypocontractility Retrospective Study Multiple Sclerosis
1. Hospital Universitario Fundación Jiménez Díaz
Presenter
Links

Poster

Abstract

Hypothesis / aims of study
Clean intermittent catheterisation(CIC) introduced by Jack Lapides in the seventies(1), is up to date, the main treatment option for patients who are unable to empty the bladder efficiently. Although this treatment modality has proven to be effective in preventing upper urinary tract impairment and urinary infections, compliance is still a major issue regarding CIC, even in neurogenic bladder patients. Routine catheterisation can be difficult and bothersome for patients, leading to a low treatment adherence and dropouts. The type and caliber of the catheter could influence treatment compliance(2). We aimed to determine the profile of patients accessing our clean intermittent catheterisation program, compliance and their preferences regarding the type and size of urinary catheter.
Study design, materials and methods
Retrospective observational study of patients who started the CIC program between 2020-2023 in our center. Patients who did not start the program or had no data regarding the type of catheter were excluded. The following catheters were offered to each patient:
Men: Lofric Origo (Wellspect), Speedicath Navi (Coloplast), and Onli (Hollister). 
Women: Lofric Sense, Speedicath, Onli, Actreen Mini-cath (Braun), Mini-set (Braun), and Hi-Lite-Set (Braun).
The initial gauge used in both sexes was 10 or 12Ch, giving patients both options for each catheter.
 After a trial period (1-2 weeks), a follow-up consultation was conducted by our nursing staff to determine the chosen catheter and gauge. More than one catheter could be selected. Demographic data, underlying pathology, number of catheterisations per day, and CIC dropout rate were also collected.
Results
A total of 148 patients were included; demographic data, underlying pathology, and dropout rate are shown in Table 1. 
In men, the most used catheter is the Speedicath Navi (52.7%), followed by Lofric Origo (35.1%) and Onli (12.2%). In women, the preferred catheter is Onli (37.1%), followed by Lofric Sense (22.9%), Mini-Cath (21.4%), Hi-Lite Set (7.2%), Mini-Cath (5.7%), and Speedicath (5.7%).
The most used gauge in men is 10Ch (49.3%), while women prefer 12Ch (56.8%). Only 4% of patients switched to a different gauge catheter.
Interpretation of results
The preferred catheter for CIC in men and women is Speedicath Navi and Onli, respectively. In our health system, each of those catheters is financed by our National Health System, so that no economic bias should be present. The 10 or 12 gauge catheters seem to be a good fit to start a CIC program in both sexes. Although this data should be interpreted carefully due to it's retrospective nature, the number of patients reviewed is high and the protocol used is unbiased. If we were to start a CIC program in a patient, a 10Ch Speedicath Navi and a 12Ch Onli could be the initial catheters advised based on this study. 
Despite of the type of catheter, dropouts in our series is 33,1%. Multiple sclerosis patients present the least dropout rate in our series (20%), but it is still a high percentage.
Concluding message
Treatment compliance is relatively low, even in neurogenic bladder patients. The type and gauge of the catheter applied could be of importance for the patient's adherence. A 10Ch Speedicath Navi and a 12Ch Onli catheter are advisable to start a CIC program. Improvements in the follow-up of patients eligible for CIC are needed to promote treatment adherence.
Figure 1 Table 1. Patients characteristics and CIC adherence
Figure 2 Male catheters
Figure 3 Female catheters
References
  1. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972 Mar;107(3):458-61.
  2. Chapple C, Abrams P, Lam T, Mangera A, Belal M, Curtis C, Emkes J, Hillery S, Irwin K, Logan K, Weston P, Yates A. A consensus statement on when to start clean intermittent self-catheterization: An untapped resource? Neurourol Urodyn. 2024 Feb;43(2):459-463.
Disclosures
Funding None Clinical Trial No Subjects Human Ethics not Req'd Only a retrospective review of our records was performed, patients history was only reviewed by staff members, whom are granted permission. No treatment or protocol out of our approved clinical practice was made. Helsinki Yes Informed Consent Yes
21/04/2025 11:14:46